Donal O’gorman
DIRECTOR
BOD
NICB
Ireland
Biography
Dr. Donal O’Gorman established, and is director of, the Centre for Preventive Medicine (CPM) at Dublin City University (DCU). The CPM integrates basic, translational and applied research to reduce the development and progression of common clinical conditions. He also leads the 3U Diabetes Partnership, an initiative integrating the research expertise of DCU, the Royal College of Surgeons in Ireland and the National University of Ireland Maynooth. Dr. O’Gorman’s research focuses on metabolic physiology, in particular the whole body regulation of insulin sensitivity and energy expenditure as well as the cellular regulation of gene expression and mitochondrial function. Dr. O’Gorman has a strong track record of working on large scale, collaborative, European research projects. DEXLIFE is an EU FP7 collaborative project to identify biomarkers that better predict the onset of type 2 diabetes and INTERCONNECT is a global initiative on diabetes gene-environment. In addition, he is on the management committee of the Joint Programming Initiative (JPI) on Diet and Diet related diseases (DEDIPAC), heads a European Space Agency group on metabolism and is a member of the ESF funded roadmap for space research in Europe (THESEUS). Dr. Donal O’Gorman established, and is director of, the Centre for Preventive Medicine (CPM) at Dublin City University (DCU). The CPM integrates basic, translational and applied research to reduce the development and progression of common clinical conditions. He also leads the 3U Diabetes Partnership, an initiative integrating the research expertise of DCU, the Royal College of Surgeons in Ireland and the National University of Ireland Maynooth. Dr. O’Gorman’s research focuses on metabolic physiology, in particular the whole body regulation of insulin sensitivity and energy expenditure as well as the cellular regulation of gene expression and mitochondrial function. Dr. O’Gorman has a strong track record of working on large scale, collaborative, European research projects. DEXLIFE is an EU FP7 collaborative project to identify biomarkers that better predict the onset of type 2 diabetes and INTERCONNECT is a global initiative on diabetes gene-environment. In addition, he is on the management committee of the Joint Programming Initiative (JPI) on Diet and Diet related diseases (DEDIPAC), heads a European Space Agency group on metabolism and is a member of the ESF funded roadmap for space research in Europe (THESEUS).
Research Interest
Molecular Biology, cell Biology, Business management
